Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXAS | Common Stock | Sale | -$1.6M | -17.1K | -2.45% | $93.64 | 681K | Oct 1, 2021 | Direct | F1, F2 |
holding | EXAS | Common Stock | 26.5K | Oct 1, 2021 | Held in 401(k) Plan | ||||||
holding | EXAS | Common Stock | 21.7K | Oct 1, 2021 | Held in Grantor Retained Annuity Trust | ||||||
holding | EXAS | Common Stock | 21.7K | Oct 1, 2021 | Held in Grantor Retained Annuity Trust | ||||||
holding | EXAS | Common Stock | 21.7K | Oct 1, 2021 | Held in Grantor Retained Annuity Trust |
Id | Content |
---|---|
F1 | The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan, which trading plan was disclosed via Form 8-K filed by Exact Sciences Corporation with the U.S. Securities and Exchange Commission on November 27, 2020. |
F2 | In addition to the shares of Common Stock reported on this Form 4, which total 772,999 shares, Mr. Conroy also holds, in the aggregate, an additional 1,207,918 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |